Literature DB >> 20501544

Facilitating pharmacokinetic studies in children: a new use of dried blood spots.

Parul Patel1, Hussain Mulla, Sangeeta Tanna, Hitesh Pandya.   

Abstract

Pharmacokinetic data are used to develop dosing regimens for medicines. The dose regimens of many drugs administered to children have historically been based on pharmacokinetic data generated in adults. The 'adult' dose was simply adjusted to the child's body weight or surface area. This practice is potentially unsafe and not acceptable to drug regulatory agencies. Obtaining pharmacokinetic data in children is beset with ethical issues and technical challenges as pharmacokinetic studies require repeated measurement of drug levels in blood. Dried blood spot (DBS) samples used in conjunction with population pharmacokinetic modelling techniques is one potential method for performing pharmacokinetic studies in children. In this article, we review the DBS technique for performing pharmacokinetic studies and highlight issues that still need to be addressed to establish DBS as a method for performing pharmacokinetic studies in children.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20501544     DOI: 10.1136/adc.2009.177592

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  22 in total

1.  Validation of a ligand binding assay using dried blood spot sampling.

Authors:  Daniel Burns; Laura Brunner; Surendran Rajendran; Beth Johnson; Mark Ma; Jin Wang
Journal:  AAPS J       Date:  2012-11-08       Impact factor: 4.009

Review 2.  Pharmacokinetic studies in infants using minimal-risk study designs.

Authors:  Julie Autmizguine; Daniel K Benjamin; P Brian Smith; Mario Sampson; Philippe Ovetchkine; Michael Cohen-Wolkowiez; Kevin M Watt
Journal:  Curr Clin Pharmacol       Date:  2014

3.  Development and validation of an assay for quantifying budesonide in dried blood spots collected from extremely low gestational age neonates.

Authors:  Joseph E Rower; David J Anderson; Catherine M Sherwin; Christopher A Reilly; Philip L Ballard; Cindy T McEvoy; Diana G Wilkins
Journal:  J Pharm Biomed Anal       Date:  2019-01-29       Impact factor: 3.935

Review 4.  Paediatric pharmacokinetics: key considerations.

Authors:  Hannah Katharine Batchelor; John Francis Marriott
Journal:  Br J Clin Pharmacol       Date:  2015-03       Impact factor: 4.335

5.  Use of dried plasma spots for the quantification of iothalamate in clinical studies.

Authors:  Andrew S Hagan; David R Jones; Rajiv Agarwal
Journal:  Clin J Am Soc Nephrol       Date:  2013-02-14       Impact factor: 8.237

6.  Developmental Pharmacokinetics and Age-Appropriate Dosing Design of Milrinone in Neonates and Infants with Acute Kidney Injury Following Cardiac Surgery.

Authors:  Tomoyuki Mizuno; Katja M Gist; Zhiqian Gao; Michael F Wempe; Jeffrey Alten; David S Cooper; Stuart L Goldstein; Alexander A Vinks
Journal:  Clin Pharmacokinet       Date:  2019-06       Impact factor: 6.447

7.  Development and validation of a UHPLC-MS/MS method to measure cefotaxime and metabolite desacetylcefotaxime in blood plasma: a pilot study suitable for capillary microsampling in critically ill children.

Authors:  Yarmarly C Guerra Valero; Tavey Dorofaeff; Jason A Roberts; Jeffrey Lipman; Mark G Coulthard; Louise Sparkes; Steven C Wallis; Suzanne L Parker
Journal:  Anal Bioanal Chem       Date:  2021-05-26       Impact factor: 4.142

8.  Comparison of the quantification of acetaminophen in plasma, cerebrospinal fluid and dried blood spots using high-performance liquid chromatography-tandem mass spectrometry.

Authors:  Rachel R Taylor; Keith L Hoffman; Björn Schniedewind; Claudia Clavijo; Jeffrey L Galinkin; Uwe Christians
Journal:  J Pharm Biomed Anal       Date:  2013-04-16       Impact factor: 3.935

9.  Determination of efavirenz in human dried blood spots by reversed-phase high-performance liquid chromatography with UV detection.

Authors:  Justin T Hoffman; Steven S Rossi; Rowena Espina-Quinto; Scott Letendre; Edmund V Capparelli
Journal:  Ther Drug Monit       Date:  2013-04       Impact factor: 3.681

10.  Pharmacokinetics of Dexmedetomidine in Infants and Children After Orthotopic Liver Transplantation.

Authors:  Mihaela A Damian; Gregory B Hammer; Mohammed H Elkomy; Adam Frymoyer; David R Drover; Felice Su
Journal:  Anesth Analg       Date:  2020-01       Impact factor: 5.108

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.